BBLG
Bone Biologics Corp
Key Financials
Operating Income
$-3234942
↑ 23.3%
Gross Profit
$0
N/A
Revenue
$1.1B
0.0%
Net Income
$-3108991
↑ 24.4%
Total Assets
$5.8M
↑ 50.1%
EPS (Diluted)
$-2.65
↑ 45.1%
Total Liabilities
$418587.00
↑ 10.8%
Shareholders' Equity
$5.4M
↑ 54.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 3/13/2026 | View on SEC |
| 424B5 | 3/13/2026 | View on SEC |
| 10-K | 3/2/2026 | View on SEC |
| 4 | 1/21/2026 | View on SEC |
| 4 | 1/21/2026 | View on SEC |
| 8-K | 1/8/2026 | View on SEC |
| 10-Q | 11/14/2025 | View on SEC |
| SCHEDULE 13G/A | 11/7/2025 | View on SEC |
| S-8 | 9/26/2025 | View on SEC |
| 8-K | 9/4/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BBLG |
| Company Name | Bone Biologics Corp |
| CIK | 1419554 |
| Sector | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3842 |
| SIC Description | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (781) 552-4452 |